{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:46:02Z","timestamp":1747161962855,"version":"3.40.5"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ijcard.2014.12.108","type":"journal-article","created":{"date-parts":[[2014,12,27]],"date-time":"2014-12-27T11:46:07Z","timestamp":1419680767000},"page":"8-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Does Trastuzumab cause permanent severe mitral regurgitation?"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9779-7578","authenticated-orcid":false,"given":"Zeki Y\u00fcksel","family":"G\u00fcnayd\u0131n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"Bekta\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayd\u0131n","family":"\u00c7ilta\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Karag\u00f6z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2014.12.108_bb0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijcard.2009.05.056","article-title":"Plasma HER2 levels are not associated with cardiac function or hypertrophy in control subjects and heart failure patients","volume":"145","author":"Posch","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2014.12.108_bb0010","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1200\/JCO.20.3.719","article-title":"Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer","volume":"20","author":"Vogel","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijcard.2014.12.108_bb0015","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ijcard.2014.08.117","article-title":"Cardiotoxicity: trastuzumab and cancer survivors","volume":"177","author":"Patan\u00e8","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2014.12.108_bb0020","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1016\/j.ijcard.2013.07.246","article-title":"Left and right ventricular effects of anthracycline and trastuzumab chemotherapy: a prospective study using novel cardiac imaging and biochemical markers","volume":"168","author":"Grover","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2014.12.108_bb0025","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1200\/JCO.2005.04.173","article-title":"Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment","volume":"23","author":"Marty","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijcard.2014.12.108_bb0030","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ijcard.2013.03.133","article-title":"Cardioncology: state of the heart","volume":"168","author":"Todaro","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2014.12.108_bb0035","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1200\/JCO.2005.13.300","article-title":"Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment","volume":"23","author":"Ewer","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijcard.2014.12.108_bb0040","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000323834","article-title":"Mitral regurgitation due to papillary muscle dyssynchrony during trastuzumab treatment","volume":"117","author":"Karabay","year":"2010","journal-title":"Cardiology"},{"key":"10.1016\/j.ijcard.2014.12.108_bb0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00392-011-0406-0","article-title":"Echocardiography signs of early cardiac impairment in patients with breast cancer and trastuzumab therapy","volume":"101","author":"Lange","year":"2012","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcard.2014.12.108_bb0050","first-page":"915","article-title":"Protocol for administration of trastuzumab based on cardiac function","volume":"39","author":"Okada","year":"2012","journal-title":"Gan To Kagaku Ryoho"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314025327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314025327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T13:27:19Z","timestamp":1537968439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527314025327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":10,"alternative-id":["S0167527314025327"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.12.108","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Trastuzumab cause permanent severe mitral regurgitation?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.12.108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}